Cargando…
Mutant Huntingtin Alters Cell Fate in Response to Microtubule Depolymerization via the GEF-H1-RhoA-ERK Pathway
Cellular responses to drug treatment show tremendous variations. Elucidating mechanisms underlying these variations is critical for predicting therapeutic responses and developing personalized therapeutics. Using a small molecule screening approach, we discovered how a disease causing allele leads t...
Autores principales: | Varma, Hemant, Yamamoto, Ai, Sarantos, Melissa R., Hughes, Robert E., Stockwell, Brent R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular
Biology
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988350/ https://www.ncbi.nlm.nih.gov/pubmed/20858895 http://dx.doi.org/10.1074/jbc.M110.125542 |
Ejemplares similares
-
Tension on JAM-A activates RhoA via GEF-H1 and p115 RhoGEF
por: Scott, David W., et al.
Publicado: (2016) -
Autophagy suppresses cell migration by degrading GEF-H1, a RhoA GEF
por: Yoshida, Tatsushi, et al.
Publicado: (2016) -
Plasma membrane restricted RhoGEF activity is sufficient for RhoA-mediated actin polymerization
por: van Unen, Jakobus, et al.
Publicado: (2015) -
p115RhoGEF activates RhoA to support tight junction maintenance and remodeling
por: Chumki, Shahana A., et al.
Publicado: (2022) -
BNIP-2 retards breast cancer cell migration by coupling microtubule-mediated GEF-H1 and RhoA activation
por: Pan, Meng, et al.
Publicado: (2020)